SCHEMBL7359190

SCHEMBL7359190

CN(C)CCC(=O)N1CCC(CC(=O)OCc2ccccc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 1/20 0.51
SIGMAR1 Q99720 1/20 0.51
NPC1 O15118 3/20 0.47
YAP1 P46937 5/20 0.46
RAB9A P51151 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
ITGB3 P05106 1/20 0.46
ITGA2B P08514 1/20 0.46
ALDH1A1 P00352 2/20 0.46
CYP2C19 P33261 1/20 0.44
POLB P06746 1/20 0.44
CHRNB2 P17787 1/20 0.43
CHRNB4 P30926 1/20 0.43
CHRNA3 P32297 1/20 0.43
CHRNA4 P43681 1/20 0.43
GRIN2B Q13224 1/20 0.43
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
KMT2A Q03164 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8791458 0.87 SMN1; SMN2 (0.50) SIGMAR1NPC1YAP1RAB9ASMN1; SMN2
SCHEMBL8790576 0.81 SMN1; SMN2 (0.46) NPC1RAB9ASMN1; SMN2ALDH1A1CYP2C19
SCHEMBL8790586 0.81 SMN1; SMN2 (0.46) NPC1RAB9ASMN1; SMN2ALDH1A1CYP2C19
SCHEMBL10853040 0.80 ALDH1A1 (0.49) TMEM97SIGMAR1NPC1RAB9ASMN1; SMN2
SCHEMBL26075634 0.79 ALDH1A1 (0.47) SIGMAR1NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL4143101 0.78 ALDH1A1 (0.59) NPC1RAB9ASMN1; SMN2ALDH1A1CYP2C19
SCHEMBL25188798 0.78 SMN1; SMN2 (0.52) NPC1RAB9ASMN1; SMN2ALDH1A1CYP2C19
SCHEMBL7363294 0.78 SMN1; SMN2 (0.48) NPC1RAB9ASMN1; SMN2CYP2C19POLB
SCHEMBL7363296 0.78 SMN1; SMN2 (0.48) NPC1RAB9ASMN1; SMN2CYP2C19POLB
SCHEMBL23798257 0.78 YAP1 (0.58) NPC1YAP1RAB9ASMN1; SMN2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996020172-A1 FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED β-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME NIPPON STEEL CORPORATION (JP) 1996-07-04 WO disclosed